Angiotensin 1-9 vs Elabela — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin 1-9 (Ang 1-9) is a 9-amino acid peptide formed when ACE2 cleaves the C-terminal leucine from angiotensin I (Ang I, 10 AA). Discovered as part of the counter-regulatory renin-angiotensin system (RAS), Ang 1-9 opposes the hypertensive and tissue-damaging actions of angi...
Calculate Angiotensin 1-9 dose →Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →| Parameter | Angiotensin 1-9 | Elabela |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical Research | Research |
| Half-Life | ~20-30 minutes | Short (minutes, estimated) |
| Typical Dose | 40-400 ng/kg/min IV infusion (animal) | 5-500 nmol/kg (animal) |
| Frequency | Acute infusion protocols | Variable |
| Route | IV/SC (research) | Subcutaneous, Intravenous |
| FDA Status | Research compound | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.